Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 2C6H7O6.Mn |
Molecular Weight | 405.1704 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Mn++].[H][C@@]1(OC(=O)C([O-])=C1O)[C@@H](O)CO.[H][C@@]2(OC(=O)C([O-])=C2O)[C@@H](O)CO
InChI
InChIKey=RSYSVNVHLXTDIR-ZZMNMWMASA-L
InChI=1S/2C6H8O6.Mn/c2*7-1-2(8)5-3(9)4(10)6(11)12-5;/h2*2,5,7-10H,1H2;/q;;+2/p-2/t2*2-,5+;/m00./s1
DescriptionSources: http://www.webmd.com/vitamins-supplements/ingredientmono-182-manganese.aspx?activeingredientid=182&Curator's Comment: description was created based on several sources, including
http://google.com/patents/WO1992012714 | https://www.google.com/patents/WO2005082386A3
Sources: http://www.webmd.com/vitamins-supplements/ingredientmono-182-manganese.aspx?activeingredientid=182&
Curator's Comment: description was created based on several sources, including
http://google.com/patents/WO1992012714 | https://www.google.com/patents/WO2005082386A3
Manganese is a mineral salt that is found in several foods including nuts, legumes, seeds, tea, whole grains, and leafy green vegetables. It is considered an essential nutrient, because the body requires it to function properly. Manganese is used for prevention and treatment of manganese deficiency, a condition in which the body doesn’t have enough manganese. It is also used for weak bones (osteoporosis), a type of “tired blood” (anemia), and symptoms of premenstrual syndrome (PMS). Manganese is sometimes included with chondroitin sulfate and glucosamine hydrochloride in multi-ingredient products promoted for osteoarthritis.
Originator
Approval Year
Sample Use Guides
Osteoporosis: 5 mg of manganese per day combined with 1000 mg of elemental calcium, 15 mg of zinc, and 2.5 mg of copper.
The daily Adequate Intake (AI) levels for manganese are: infants birth to 6 months, 3 mcg; 7 to 12 months, 600 mcg; children 1 to 3 years, 1.2 mg; 4 to 8 years 1.5 mg; boys 9 to 13 years, 1.9 mg; boys 14 to 18 years, 2.2 mg; girls 9 to 18 years, 1.6 mg; men age 19 and older, 2.3 mg; women 19 and older, 1.8 mg; pregnant women age 14 to 50, 2 mg; breastfeeding women, 2.6 mg.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
3676 (Number of products:1)
Created by
admin on Sat Dec 16 02:06:42 GMT 2023 , Edited by admin on Sat Dec 16 02:06:42 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000076486
Created by
admin on Sat Dec 16 02:06:42 GMT 2023 , Edited by admin on Sat Dec 16 02:06:42 GMT 2023
|
PRIMARY | |||
|
SUB14467MIG
Created by
admin on Sat Dec 16 02:06:42 GMT 2023 , Edited by admin on Sat Dec 16 02:06:42 GMT 2023
|
PRIMARY | |||
|
DTXSID001020116
Created by
admin on Sat Dec 16 02:06:42 GMT 2023 , Edited by admin on Sat Dec 16 02:06:42 GMT 2023
|
PRIMARY | |||
|
332B7O278V
Created by
admin on Sat Dec 16 02:06:42 GMT 2023 , Edited by admin on Sat Dec 16 02:06:42 GMT 2023
|
PRIMARY | |||
|
16351-10-3
Created by
admin on Sat Dec 16 02:06:42 GMT 2023 , Edited by admin on Sat Dec 16 02:06:42 GMT 2023
|
PRIMARY | |||
|
332B7O278V
Created by
admin on Sat Dec 16 02:06:42 GMT 2023 , Edited by admin on Sat Dec 16 02:06:42 GMT 2023
|
PRIMARY | |||
|
90479050
Created by
admin on Sat Dec 16 02:06:42 GMT 2023 , Edited by admin on Sat Dec 16 02:06:42 GMT 2023
|
PRIMARY | |||
|
1144960
Created by
admin on Sat Dec 16 02:06:42 GMT 2023 , Edited by admin on Sat Dec 16 02:06:42 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD